Our CEO Joe Farrell traveled to London in March 2024 for Advanced Therapies Congress, Europe’s largest cell and gene therapy conference and exhibition. This event brings together the world leaders in ATMP development and technology that are driving the industry forward.

Inspired by 250 speakers and 100 start-ups, the Advanced Therapies Congress featured speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, and regulators.

Here at Alethium Health, we are thrilled about our role in supporting the next-generation of clinical research through our robust digital platform focused on patient-centric and value-driven solutions.

The Alethium eClinical Platform is automated to scale in real-time across multiple languages without incurring extra costs or schedule disruptions. Operating as a small and singularly focused team with a full suite of services, Alethium is devoted to the success of each trial, regardless of their stakes or risk factors.